EVELYNE M LOYER to Treatment Outcome
This is a "connection" page, showing publications EVELYNE M LOYER has written about Treatment Outcome.
Connection Strength
0.141
-
Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009 Dec 02; 302(21):2338-44.
Score: 0.020
-
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol. 2019 04; 133:54-61.
Score: 0.010
-
Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut. 2018 06; 67(6):1095-1102.
Score: 0.009
-
Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence. J Comput Assist Tomogr. 2017 Jul/Aug; 41(4):607-613.
Score: 0.009
-
Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma. J Gastrointest Surg. 2016 Apr; 20(4):741-7.
Score: 0.008
-
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Br J Haematol. 2014 Oct; 167(2):177-84.
Score: 0.007
-
Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis. J Vasc Interv Radiol. 2014 Apr; 25(4):608-17.
Score: 0.007
-
Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013 Jun; 257(6):1079-88.
Score: 0.006
-
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013 Feb; 15(2):91-103.
Score: 0.006
-
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20; 30(36):4566-72.
Score: 0.006
-
Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg. 2011 Jul; 98(7):1003-9.
Score: 0.006
-
Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Cancer. 2011 Oct 01; 117(19):4484-92.
Score: 0.006
-
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011 Mar 10; 29(8):1083-90.
Score: 0.005
-
Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010 May 20; 28(15):2549-55.
Score: 0.005
-
Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007 Nov; 94(11):1386-94.
Score: 0.004
-
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May; 141(5):460-6; discussion 466-7.
Score: 0.004
-
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 2006 Mar; 47(3):481-5.
Score: 0.004
-
Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics. 2006 Mar-Apr; 26(2):481-95.
Score: 0.004
-
Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma. Cancer. 2005 Aug 15; 104(4):781-7.
Score: 0.004
-
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. Clin Cancer Res. 2004 Aug 15; 10(16):5432-8.
Score: 0.004
-
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33.
Score: 0.003
-
Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics. 2001 Oct; 21 Spec No:S41-54.
Score: 0.003
-
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. Clin Cancer Res. 1997 Sep; 3(9):1501-5.
Score: 0.002